These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 4572126)

  • 1. Enhanced survival of canine renal allografts of ALS- treated dogs given bone marrow.
    Caridis DT; Liegeois A; Barrett I; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):671-4. PubMed ID: 4572126
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro modification of donor bone marrow used to produce enhanced graft survival in antilymphocyte serum (ALS)-treated mice.
    Gozzo JJ; Wood ML; Pompei R; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):853-6. PubMed ID: 4572148
    [No Abstract]   [Full Text] [Related]  

  • 3. The efficiency of sheep antidog antilymphocyte serum (SADALS) in the prolongation of canine heart allografts.
    Halpern B; Cachera JP; Lacombe M; Hathaway A; Crepin Y; Hung BM; Lacassagne JP; Leandri J; Laurent D; Dubost C; de Mendoza M
    Transplant Proc; 1969 Mar; 1(1):467-9. PubMed ID: 4944261
    [No Abstract]   [Full Text] [Related]  

  • 4. Survival of canine renal allografts after antilymphocytic serum and bone-marrow treatment.
    Caridis DT; Lieogeois A; Barret I; Lytle BW; Monaco AP
    Br J Surg; 1972 Apr; 59(4):311. PubMed ID: 4553597
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of prior blood transfusions on marrow grafts: abrogation of sensitization by procarbazine and antithymocyte serum.
    Storb R; Floersheim GL; Weiden PL; Graham TC; Kolb HJ; Lerner KG; Schroeder ML; Thomas ED
    J Immunol; 1974 Apr; 112(4):1508-16. PubMed ID: 4592604
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of permanent survival of canine renal allografts following a limited course of ALS treatment.
    Shanfield I; Wolf JS; Wren SF; MacLean LD; Hume DM
    Transplant Proc; 1973 Mar; 5(1):533-4. PubMed ID: 4572113
    [No Abstract]   [Full Text] [Related]  

  • 7. An in vitro reaction between lymphoid cells and target fibroblastic cells: a possible model for in vivo rejection of haemopoietic allografts.
    Mayhew E; Bennett M
    Immunology; 1971 Jul; 21(1):123-36. PubMed ID: 4934136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific tolerance to canine renal allografts following treatment with fractionated bone marrow and antilymphocyte serum.
    Hartner WC; De Fazio SR; Markees TG; Maki T; Monaco AP; Gozzo JJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):476-7. PubMed ID: 3274810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological enhancement of renal allografts.
    Stuart FP; McKearn TJ; Fitch FW
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):53-8. PubMed ID: 4140597
    [No Abstract]   [Full Text] [Related]  

  • 10. Survey of the current status of the clinical uses of antilymphocyte serum.
    Monaco AP; Codish SD
    Surg Gynecol Obstet; 1976 Mar; 142(3):417-26. PubMed ID: 766248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of augmented graft survival in mice after ALS and bone marrow infusion.
    Wood ML; Heppner G; Gozzo JJ; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):691-6. PubMed ID: 4572128
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of unresponsiveness to canine renal allografts by total body irradiation and bone marrow transplantation.
    Rapaport FT; Cannon FD; Blumenstock DA; Watanabe K; Ferrebee JW
    Nat New Biol; 1972 Feb; 235(58):191-2. PubMed ID: 4551282
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanism for prolonged survival of pig renal allografts.
    Perper RJ; Bowersox BE; Van Gorder TJ
    Transplantation; 1971 Jun; 11(6):505-13. PubMed ID: 4931451
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolonged survival of renal allografts in tissue typed beagles by treatment with ALS and donor bone marrow.
    Jeekel J; Obertop H; Westbroek DL; Vriesendorp HM
    Transplantation; 1976 Nov; 22(5):534-7. PubMed ID: 793111
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of cytotoxic (sensitization) and enhancing (prolonged survival) responses by injection of lymphoid cells in ALS-treated mice.
    Wood ML; Monaco AP
    Transplant Proc; 1979 Jun; 11(2):1456-7. PubMed ID: 382539
    [No Abstract]   [Full Text] [Related]  

  • 16. The current status of transplantation immunology.
    Lessof MH
    Sci Basis Med Annu Rev; 1972; ():16-32. PubMed ID: 4565772
    [No Abstract]   [Full Text] [Related]  

  • 17. Observations on the effect of horse anti-pig leucocyte serum in suppressing the rejection of renal allografts in pigs.
    White HJ; Symes MO; Golby MS; Jago RH; Ponsford F; Lucke VM; Lucke JN; Jaffe WP
    Br J Surg; 1971 Nov; 58(11):859. PubMed ID: 4942029
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of anti-donor serum (ADS) and donor cells on renal allograft survival in DL-A tissue-typed littermate beagles.
    Jeekel J; Obertop H; Vriesendorp HM; McDicken I; Westbroek DL
    Transplant Proc; 1975 Sep; 7(3):435-8. PubMed ID: 1099744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ia-positive donor-specific bone marrow cells prolong renal allografts in dogs treated with fractionated lymphoid irradiation.
    Watanabe K; Taniai S; Sato K; Sonoda K; Masaki Y; Takahara H; Matsubayashi T; Kashiwagi N
    Transplant Proc; 1987 Feb; 19(1 Pt 1):632-4. PubMed ID: 2978927
    [No Abstract]   [Full Text] [Related]  

  • 20. Modification of rejection in rat renal allografts across a strong histocompatibility barrier.
    Desai SB
    Br J Surg; 1971 Nov; 58(11):859-60. PubMed ID: 4942033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.